CHILDREN'S ZYRTEC CHEWABLE OTC
Generic Name and Formulations:
Cetirizine HCl 5mg, 10mg; chew tabs; grape flavor.
McNeil Consumer Healthcare
Indications for CHILDREN'S ZYRTEC CHEWABLE:
Adults and Children:
Chew tabs: may take with or without water. For doses <5mg: use syrup. <2yrs: not recommended. 2–6yrs: initially 2.5mg once daily; max 5mg once daily or 2.5mg every 12hrs. ≥6yrs: initially 5–10mg once daily. ≥65yrs: use chew tabs or syrup: 5mg once daily. Hepatic or renal impairment: individualize.
Hives Relief: not used for prevention or as a substitute for epinephrine. Hepatic or renal dysfunction. Pregnancy. Nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants.
Drowsiness, somnolence, fatigue, dry mouth, pharyngitis. Children: headache, pharyngitis, GI upset/pain, cough, somnolence, diarrhea, epistaxis, bronchospasm, fatigue, irritability, insomnia.
Tabs—5, 14, 30, 45, 75; Liquid gels—12, 25, 40; Chew tabs 5mg—5, 10mg—12, 24; Hives Relief tabs—14; Syrup—4oz
Endocrinology Advisor Articles
- ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes
- Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- HbA1c Levels Affect Serum Phospholipids, Inflammation inT2D, CVD
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Common Plant-Derived Oils May Contain Endocrine-Disrupting Chemicals
- Red Meat Consumption Linked to Insulin Resistance and Steatohepatitis
- Effect of High Androgen Levels on Cardiovascular Risk in Postmenopausal Women
- Fertility in Women Negatively Affected by Asthma Medications
- Glucocorticoid Use in COPD Does Not Increase Fracture Risk